My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
November 2017
Maintaining Our Momentum
Paul Auwaerter, MD, MBA, FIDSA
IDSA President

Thank you for the welcome to the start of my term as President of IDSA. I am honored to hold this position in an organization that, like many of our members, shares deep commitments to advance our knowledge of infectious diseases and to improve the care of our patients. When I was in the early years of my career, I thought of the Society mainly as an organization that produced an annual meeting (now IDWeek) and peer-reviewed journals, Clinical Infectious Diseases, The Journal of Infectious Diseases, and now Open Forum Infectious Diseases.

Along with clinical practice guidelines, each of these member benefits remains highly important to my practice of infectious diseases. As my time with the Society progressed, working with the many superb staff of our Society, I came to value the outstanding reputation IDSA has earned in advising policymakers and regulators. Such work is hard and the process slower than desired, but is so important to our lives as infectious disease professionals.

IDSA Launches Antimicrobial Stewardship Centers of Excellence Program

Providence Saint John’s Health Center of Santa Monica, California, and Summa Health of Akron, Ohio, are the first recipients of IDSA’s Antimicrobial Stewardship Centers of Excellence (CoE) designation.

Updated Guideline on Infectious Diarrhea Now Available

IDSA has published in Clinical Infectious Diseases a new guideline on the detection and treatment of infectious diarrhea. New culture-independent tests are much more sensitive than traditional diagnostic methods in detecting the cause of infectious diarrhea, but because these tests are so sensitive and may detect multiple organisms, infectious disease expertise may be necessary to interpret the clinical significance and facilitate appropriate public health surveillance, according to the new guidelines.

IDWeek 2017 Recap

IDWeek 2017 was a record-setting year as more than 7,500 professional attendees from 90 countries converged on San Diego last month.

Journal Club
  • Is Vancomycin Plus a Beta-Lactam Better for Surgical Prophylaxis than Either Alone?
  • Higher Mortality With Higher Levels of CMV: Is It the Virus or the Treatment?
  • Quantifying Real Tuberculosis Risk with QuantiFERON: Is there a “Borderline” Category?
Upcoming dates to remember

The combined meeting of IDSA, SHEA, HIVMA, and PIDS, Oct. 3-7 in San Francisco, CA. See you there!

HIVMA Releases Guideline on HIV and Chronic Pain
ACIP Makes New Recommendations on Shingles, Mumps Vaccines
Weighing in on HHS Report on Vaccine Innovation
Updates on NIHís Next Generation Researchers Initiative
IDSA to UHC: Donít Deny Payment for Cognitive Services
Reimbursement for Telemedicine Could Get Easier
How to Stay Abreast of CMSís Quality Payment Program
IDSA Remains Committed to Fighting Antimicrobial Resistance
FY2018 Funding News
IDSA Continues to Press for Diagnostics Reimbursement
FDA Public Workshop on Antimicrobial Susceptibility Tests
IDSA Member Testifies at New York State Hearing on Lyme Disease
Science Speaks Covers IDWeek, Union World Conference on Lung Health
Congressional Study Tour to CDC Global Health
Fellowship in Stewardship and Resistance Receives CDC Funding
HIVMA Clinical Fellowship and Medical Students Program
PCORI Funding Announcement: Community-Acquired Pneumonia
Maintaining Our Momentum
IDSA Launches Antimicrobial Stewardship Centers of Excellence Program
Updated Guideline on Infectious Diarrhea Now Available
IDWeek 2017 Recap
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.

Unsubscribe here